(Q41486771)

1 October 2017

title

Hepatitis B virus vaccine: a randomized trial of a reduced dose regimen in hemodialysis patients (English)

1 reference

1 October 2017

1 reference

Aronoff GR

1

1 reference

1 October 2017

Maxwell DR

series ordinal

2

1 reference

1 October 2017

Batteiger BE

series ordinal

3

1 reference

1 October 2017

Fineberg NS

series ordinal

4

1 reference

1 October 2017

publication date

1 September 1985

1 reference

American Journal of Kidney Diseases

1 October 2017

published in

1 reference

1 October 2017

volume

6

1 reference

1 October 2017

issue

3

1 reference

1 October 2017

page(s)

170-172

1 reference

Serological and epidemiological studies of hepatitis B in haemodialysis units

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Hepatitis B vaccine: immune responses in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Active hepatitis B vaccination of dialysis patients and medical staff

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Hepatitis B: its prevention by vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2885%2980021-4

7 January 2021

10.1016/S0272-6386(85)80021-4

Identifiers

DOI

1 reference

1 October 2017

1 reference